12:00 01/08/2015 Biotech Stocks you should dump: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS ...
Biotech Stocks you should dump: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS ...
Wall Street Point - 19 hours ago
On the trading floor, shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) droped 3.91% to close at $0.182. The company on July 28, 2015 announced that it has granted to German life sciences entrepreneurs with a proven track-record of funding the ...
Important News: CONSOL Energy Inc. (NYSE:CNX), Aeterna Zentaris Inc. (NASDAQ ... - Citizen Dispatch
Maxim Group Reaffirms "Buy" Rating for AEterna Zentaris (AEZS) - sleekmoney

12:37 29/07/2015 Company Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Announces Optimized ...
Company Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Announces Optimized ...
Smarter Analyst - Jul 29, 2015
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced it has selected an optimized Erk inhibitor molecule for development, thus achieving another important milestone in the development of a new class of potential cancer therapies.
Active Stocks in Action: Frontier Communications Corp (NASDAQ:FTR), AEterna ... - wsnewspublishers

12:37 27/07/2015 Stock Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Commences Promotional ...
Stock Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Commences Promotional ...
Smarter Analyst - Jul 27, 2015
AEterna Zentaris Inc. (USA) (NASDAQ:AEZSׁ) announced that it has started promoting Saizen® [somatropin (rDNA origin) for injection] in 25 territories in the United States, pursuant to its co‑promotion agreement signed this past May with EMD Serono, the ...
Active Stocks Roundup: Southwestern Energy Company (NYSE:SWN), AEterna ... - wsnewspublishers
Biotech Stocks Getting Lots of Love - AEterna Zentaris Inc. (USA) (NASDAQ:AEZS ... - Wall Street Observer

13:11 30/06/2015 Stock Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Completes Patient ...
Stock Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Completes Patient ...
Smarter Analyst - Jun 30, 2015
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced it has reached its goal of recruiting 500 patients for its pivotal Phase 3 ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) clinical study with zoptarelin doxorubicin in women with advanced, ...
Mid Day Alert: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Pieris ... - Market News Call
Hot Action in 3 Biotech Stocks - Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN ... - Wall Street Observer

12:26 18/06/2015 Company Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Announces Extension ...
Company Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Announces Extension ...
Smarter Analyst - Jun 18, 2015
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced that it has received notice from the NASDAQ Listing Qualifications Department (“NASDAQ”) determining that the Company is eligible for an additional 180 calendar day period, until December 14, 2015 ...
AEterna Zentaris Inc. (NASDAQ:AEZS) Price Target Update - OTC Outlook
Aeterna Zentaris Announces Extension to Regain Compliance with NASDAQ's ... - Canada NewsWire (press release)

21:37 21/05/2015 HC Wainwright Pounds the Table on AEterna Zentaris Inc. (USA)
HC Wainwright Pounds the Table on AEterna Zentaris Inc. (USA)
Smarter Analyst - May 21, 2015
H.C. Wainwright analyst Swayampakula Ramakanth was out pounding the table on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) Thursday, reiterating a Buy rating and price target of $1.25, which represents a potential upside of about 315% from where the ...

19:09 11/05/2015 AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) a Hold: Canaccord Genuity
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) a Hold: Canaccord Genuity
Markets.co - May 11, 2015
In a research note issued to investors, Neil Maruoka at Canaccord Genuity Reiterated their Hold rating on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS). The analyst placed a $0.70 price target on the stock which indicates a 45.83% upside to the last ...
Oversold Stocks: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), NewLink Genetics ... - Wall Street Observer
Canaccord Insights Update: Apple Inc. (AAPL), NVIDIA Corporation, (NVDA ... - Smarter Analyst

0:15 09/05/2015 Canaccord Offers Commentary on AEterna Zentaris Inc. (USA) Following Agreement ...
Canaccord Offers Commentary on AEterna Zentaris Inc. (USA) Following Agreement ...
Smarter Analyst - May 8, 2015
In a research report released today, Canaccord Genuity analyst Neil Maruoka reiterated a Hold rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) with a $0.70 price target, after the company announced an agreement with EMD Serono that will ...
Aeterna Zentaris and EMD Serono Finalize Promotional Services Agreement for ... - PR Newswire (press release)
Æterna Zentaris (AEZS), EMD Serono Finalize Promotional Services Agreement ... - StreetInsider.com

16:52 24/03/2015 HC Wainwright Reiterates Neutral on AEterna Zentaris Inc. (USA) Following ...
HC Wainwright Reiterates Neutral on AEterna Zentaris Inc. (USA) Following ...
Smarter Analyst - Mar 24, 2015
H.C. Wainwright analyst Swayampakula Ramakanth came out with a few insights on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), after the company released its fourth-quarter results last Monday.

21:33 19/03/2015 Maxim Reiterates Buy on AEterna Zentaris Inc. (USA) Following 4Q:14 Update
Maxim Reiterates Buy on AEterna Zentaris Inc. (USA) Following 4Q:14 Update
Smarter Analyst - Mar 19, 2015
Maxim Group's healthcare analyst Jason Kolbert came out with a research note on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), after the company reported its fourth-quarter financial results and provided a corporate update.